Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: A first-in-man study

Circulation: Cardiovascular Interventions

Volumn 7, Issue 6, 2014, Pages 806-812

  Frey, Norbert ^a   Linke, Axel ^b   Süselbeck, Tim ^c   Müller Ehmsen, Jochen ^d   Vermeersch, Paul ^e   Schoors, Danny ^f   Rosenberg, Mark ^a   Bea, Florian ^g   Tuvia, Shmuel ^h   Leor, Jonathan ⁱ  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Diakoniekrankenhaus Mannheim   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e MIDDELHEIM HOSPITAL   (Belgium)

^f UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h BIOLINERX LTD   (Israel)

ⁱ TEL AVIV UNIVERSITY   (Israel)

Author keywords

Coronary disease; Heart failure; Myocardial infarction; Ventricular remodeling

Indexed keywords

ALGINIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CONTRAST MEDIUM; CREATINE KINASE; GLUCONATE CALCIUM; ALGINATES; CALCIUM GLUCONATE; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGELS;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BIORESORBABLE SCAFFOLD; BRADYCARDIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONNECTIVE TISSUE DISEASE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CREATINE KINASE BLOOD LEVEL; CROSS LINKING; ECHOCARDIOGRAPHY; EPISTAXIS; FAINTNESS; FEASIBILITY STUDY; FEMALE; FIRST IN HUMAN STUDY; FOLLOW UP; GASTROINTESTINAL DISEASE; HEADACHE; HEART BLOCK; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HEART MUSCLE PERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYDROGEL; INFECTION; INFESTATION; INJECTABLE BIOABSORBABLE SCAFFOLD; KIDNEY FAILURE; MALE; MEDIASTINUM DISEASE; MENTAL DISEASE; METABOLIC DISORDER; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; SKIN DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX DISEASE; THORAX PAIN; TREATMENT DURATION; VASCULAR DISEASE; ABSORBABLE IMPLANTS; ADVERSE EFFECTS; BELGIUM; CLINICAL TRIAL; FEASIBILITY STUDIES; GERMANY; HEART FUNCTION TESTS; HUMANS; HYDROGELS; INJECTIONS, INTRA-ARTERIAL; METHODS; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PHYSIOPATHOLOGY; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REGENERATIVE MEDICINE; THERAPY; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

ABSORBABLE IMPLANTS; ADULT; AGED; ALGINATES; BELGIUM; CALCIUM GLUCONATE; FEASIBILITY STUDIES; FEMALE; GERMANY; GLUCURONIC ACID; HEART FUNCTION TESTS; HEXURONIC ACIDS; HUMANS; HYDROGELS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REGENERATIVE MEDICINE; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84925840655     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.114.001478     Document Type: Article

References (22)

1. Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, Santoro GM, Antoniucci D. Left ventricular remodeling after primary coronary angioplasty: Patterns of left ventricular dilation and long-term prognostic implications. Circulation. 2002;106: 2351-2357.
2. Savoye C, Equine O, Tricot O, Nugue O, Segrestin B, Sautière K, Elkohen M, Pretorian EM, Taghipour K, Philias A, Aumégeat V, Decoulx E, Ennezat PV, Bauters C; REmodelage VEntriculaire Study Group. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). Am J Cardiol. 2006;98: 1144-1149.
3. Jhund PS, McMurray JJ. Heart failure after acute myocardial infarction: A lost battle in the war on heart failure? Circulation. 2008;118: 2019-2021.
4. Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: Mechanisms: Part 1 of 2. Circulation. 2013;128: 388-400.
5. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128: E240-e327.
6. Xie M, Burchfield JS, Hill JA. Pathological ventricular remodeling: Therapies: Part 2 of 2. Circulation. 2013;128: 1021-1030.
7. Eschalier R, Fertin M, Fay R, Bauters C, Zannad F, Pinet F, Rossignol P. Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: Insights from the REVE-2 study. Circ Heart Fail. 2013;6: 1199-1205.
8. Christia P, Frangogiannis NG. Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest. 2013;43: 986-995.
9. Leor J, Tuvia S, Guetta V, Manczur F, Castel D, Willenz U, Petneházy O, Landa N, Feinberg MS, Konen E, Goitein O, Tsur-Gang O, Shaul M, Klapper L, Cohen S. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine. J Am Coll Cardiol. 2009;54: 1014-1023.
10. Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, Cohen S, Leor J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008;117: 1388-1396.
11. Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D, Kamm RD, Zhang S, Lee RT. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation. 2005;111: 442-450.
12. Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol. 2004;44: 654-660.
13. Radisic M, Christman KL. Materials science and tissue engineering: Repairing the heart. Mayo Clin Proc. 2013;88: 884-898.
14. Sabbah HN, Wang M, Gupta RC, Rastogi S, Ilsar I, Sabbah MS, Kohli S, Helgerson S, Lee RJ. Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. JACC Heart Fail. 2013;1: 252-258.
15. Dauber IM, VanBenthuysen KM, McMurtry IF, Wheeler GS, Lesnefsky EJ, Horwitz LD, Weil JV. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res. 1990;66: 986-998.
16. Schumacher CA, Baartscheer A, Coronel R, Fiolet JW. Energy-dependent transport of calcium to the extracellular space during acute ischemia of the rat heart. J Mol Cell Cardiol. 1998;30: 1631-1642.
17. Brownlee IA, Allen A, Pearson JP, Dettmar PW, Havler ME, Atherton MR, Onsøyen E. Alginate as a source of dietary fiber. Crit Rev Food Sci Nutr. 2005;45: 497-510.
18. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105: 539-542.
19. Bale S, Baker N, Crook H, Rayman A, Rayman G, Harding KG. Exploring the use of an alginate dressing for diabetic foot ulcers. J Wound Care. 2001;10: 81-84.
20. Cabrales P, Tsai AG, Intaglietta M. Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemodilution. Am J Physiol Heart Circ Physiol. 2005;288: H1708-H1716.
21. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev. 2001;101: 1869-1879.
22. Oliveira SM, Barrias CC, Almeida IF, Costa PC, Ferreira MR, Bahia MF, Barbosa MA. Injectability of a bone filler system based on hydroxyapatite microspheres and a vehicle with in situ gel-forming ability. J Biomed Mater Res B Appl Biomater. 2008;87: 49-58.